Close

Vitae Pharmaceuticals (VTAE) Announces BI187004/VTP-34072 Phase 2 Missed Primary Efficacy Endpoint

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/26/2024

1. META
2. GOOGL
3. CMG
4. MSFT
5. LRCX
6. IBM
7. SPY
8. INTC
9. SNAP
10. BA


Go back to Vitae Pharmaceuticals (VTAE) Announces BI187004/VTP-34072 Phase 2 Missed Primary Efficacy Endpoint
(NASDAQ: VTAE) Delayed: 21.00 --0 (-0%)
Previous Close $21.00    52 Week High $21.04 
Open $1.67    52 Week Low $4.08 
Day High $21.00    P/E N/A 
Day Low $21.00    EPS $0.00 
Volume 192,326